---
title: "NHS National Framework for Tocilizumab - March 2024"
ocid: "ocds-h6vhtk-041db8"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-041db8"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-041db8.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-041db8.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2024-04-08"
---

# NHS National Framework for Tocilizumab - March 2024

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-041db8

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-041db8)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-041db8.json)

## Summary

The NHS England has completed the procurement process for the NHS National Framework for Tocilizumab - March 2024. This tender falls under the goods category and involves pharmaceutical products. The framework covers two regions: LONDON and SOUTH OF ENGLAND, and NORTH OF ENGLAND and MIDLANDS AND EAST, with an initial period from 1 March 2024 to 28 February 2025, extendable up to 24 months. The procurement method used was the open procedure, and the authority for this tender is NHS England. The award was granted to Roche Products Ltd and Fresenius Kabi Limited.

This tender for the NHS National Framework for Tocilizumab presents a lucrative opportunity for businesses operating in the pharmaceutical industry. Companies specialising in the production and supply of pharmaceutical products, particularly in the specified regions, would be well-suited to compete for potential contract extensions. By engaging in this procurement process, businesses can establish long-term partnerships with NHS England and contribute to the provision of healthcare services to the identified regions.

## Notice

Project Title: NHS National Framework for Tocilizumab - March 2024

Offer reference number: CM/PHR/23/5702

CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. 

CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

### Lot Information

CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND.

CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AN

CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/011334-2024 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 8 Apr 2024 |
| Submission deadline | 3 Jan 2024 |
| Future notice date | Not specified |
| Award date | 11 Mar 2024 |
| Contract period | 1 Mar 2024 - 28 Feb 2025 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £150,000,000 |
| Lots value | £150,000,000 |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LEEDS |
| Post town | Leeds |
| Postcode | LS2 7UE |
| Country | England |
| ITL 1 | TLE Yorkshire and The Humber |
| ITL 2 | TLE4 West Yorkshire |
| ITL 3 | TLE42 Leeds |
| Local authority | Leeds |
| Electoral ward | Hunslet & Riverside |
| Westminster constituency | Leeds South |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 2 |
| Supplier names | FRESENIUS KABI; ROCHE PRODUCTS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 8 Apr 2024 at 16:44 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/011334-2024
- 29 Nov 2023 at 14:39 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/035227-2023

## Notice URLs

- http://health.atamis.co.uk
- https://health-family.force.com/s/Welcome
- https://supplierregistration.cabinetoffice.gov.uk
- https://www.england.nhs.uk/
- https://www.judiciary.uk/courts-and-tribunals/high-court/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-041db8. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-041db8.json.